International Bladder Cancer Group 2025 Videos

IBCG Task Force Plan to Develop Patient-Reported Outcome Tool for Bladder Cancer - Sarah Psutka

IBCG Recommendations for Intermediate-Risk NMIBC Definitions and Management - Roger Li

Limitations of Urine-Based Biomarkers for Replacing Cystoscopy in Hematuria - Wei Shen Tan

Multidisciplinary and Global Perspectives on Bladder Cancer Management - Shilpa Gupta, Patrick Hensley & Roger Li

Assessing Baseline Bladder Function for Patients Considering Trimodal Therapy - Comron Hassanzadeh

Assessment of Urine-Based Tests and Adjuncts in Bladder Cancer Guidelines - Laura Bukavina

International Initiative to Define and Quantify Local Bladder Side Effects - Patrick Hensley

Addressing Limitations in Current Toxicity Reporting for Bladder Cancer Therapies - Shilpa Gupta

Biomarkers for Guiding Bladder Cancer Treatment Decisions - Andrea Necchi

RNA and DNA Biomarkers in Trimodal Therapy for Bladder Cancer - Kent Mouw